AMP is WAC: Who It's For and Who Sponsors It

Covers: US pharmaceutical policy, Medicare Part D, 340B regulations, PBM reform, drug pricing, reimbursement, and market access strategies.
For: Pharmaceutical executives, healthcare policy professionals, market access leaders, and healthcare consultants.
Best for: Life sciences professionals navigating drug pricing, reimbursement regulations, and healthcare policy shifts.
Skip if: General consumers looking for personal healthcare advice or patient advocacy tips.

Start with

AMP is WAC -- 10/16/26: Explores how Most Favored Nation policies impact drug launch strategies and European market access.
AMP is WAC -- 09/11/26: Provides an in-depth policy deep dive into pharmacy benefit manager (PBM) news and trends.
AMP is WAC -- 08/21/26: Explains 505(b)2 classifications, PBM reform realities, 340B definitions, and Part D coverage gaps.

Summarised by AI from 12 recent issues. Audience size is not included. Prices are not included. Report a mistake.